53 results
424B5
51f4l6
15 Jun 23
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
2ty3 yssxq1
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.1
rm8rmjiu6uh 83afn
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
424B5
gmgsz
16 May 22
Prospectus supplement for primary offering
5:17pm
8-K
EX-99.1
316995kw
5 May 22
Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
7:05am
424B5
6smhltucyebac7g7 3xj
27 Apr 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
x41hr9pddn0ji
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
i6w6b3q
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
zjy762pc077 rmresjp
11 Apr 22
Zentalis Pharmaceuticals Announces Overview of Clinical and Preclinical Data Presented at AACR
4:43pm
8-K
83xc64mof es6
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm